With the acquisition of PRN, iMedX expands its reach in the Washington DC metro area and beyond. PRN’s employees in India will be absorbed by iMedX’s subsidiary Worldtech.

ImedX said that with the integration of TurboScribe and Electronic Medical Record (EMR) products, customers will progress towards a paperless environment, a higher quality of care, and pave the way for adherence to the Obama administration’s ‘meaningful use’ guidelines.

Additionally, PRN customers can take advantage of iMedX’ other Internet-based products such as its TurboRecord iMedX’s low-cost, subscription-based EMR, and their ePrescribing product TurboRx for error-free prescribing through pharmacies across the country.

Venkat Sharma, president and CEO of iMedX, along with the current iMedX management team, will continue to lead the combined companies. Gabriela (Gaby) Perazzo, founder and CEO of PRN, will work with iMedX through the transition even as she develops her passion in online newsletters and seminars.

Venkat Sharma, president and CEO of iMedX, said: “With the evolution of Federal Government requirements for technology in healthcare, many small transcription companies are realizing they lack the resources to keep pace. With the evolution of the Obama administration’s ‘meaningful use’ guidelines, it is imperative to use the online delivery and portability of medical documentation that iMedX provides.”

“Following on the heels of acquisition of Medware, MedeFLow, and Worldtech previous year, this acquisition is an essential part of our strategy to grow through direct sales as well as acquisitions, and propagate TurboScribe software throughout our transcription customer base, concurrently rolling out other products to help the physician lower costs and increase revenues. Through this strategy iMedX intends to grow into a major force in the clinical documentation software and services industry.”